Table 2.
Clinical Baseline Characteristics in ND and nND.
| All |
nND (n = 63) |
ND (n = 17) |
p-value | |
|---|---|---|---|---|
| Clinical items | ||||
| Age (years) | 67.91 | 66.54 ± 13.65 | 73.00 ± 11.34 | 0.077 |
| Sex (male; n %) | 48 (60) | 43 (89.6) | 5 (10.4) | 0.004* |
| Time of reperfusion (h) | 8.26 (5–10.75) | 8.71 ± 5.31 | 6.62 ± 3.41 | 0.129 |
| Basal NIHSS | 16 (12–20) | 15.61 ± 5.11 | 17.76 ± 6.84 | 0.158 |
| Intravenous thrombolysis (n %) | 32 (40) | 28 (87.5) | 4 (12.5) | 0.118 |
| Medical history | ||||
| Hypertension (n %) | 52 (65) | 38 (73.1) | 14 (26.9) | 0.091 |
| Diabetes mellitus (n %) | 26 (32.5) | 18 (69.2) | 8 (30.8) | 0.149 |
| Hyperlipide (n %) | 27 (33.8) | 24 (88.9) | 3 (11.1) | 0.114 |
| Coronary artery disease (n %) | 14 (17.5) | 8 (57.1) | 6 (42.9) | 0.030* |
| Atrial fibrillation (n %) | 39(47.5) | 27 (69.2) | 12 (30.8) | 0.042* |
| WBC, 10∧9/L | 10.21 ± 4.01 | 10.02 ± 3.53 | 10.90 ± 5.51 | 0.427 |
| Neu, 10∧9/L | 8.18 ± 4.02 | 7.97 ± 3.69 | 8.95 ± 5.13 | 0.375 |
| TC, mmol/L | 4.48 ± 1.22 | 4.57 ± 1.23 | 4.05 ± 1.08 | 0.157 |
| TG, mmol/L | 1.36 ± 1.55 | 1.42 ± 1.70 | 1.12 ± 0.33 | 0.530 |
| HDL, mmol/L | 0.97 ± 0.22 | 0.97 ± 0.22 | 0.98 ± 0.25 | 0.816 |
| LDL, mmol/L | 2.74 ± 0.90 | 2.83 ± 0.89 | 2.35 ± 0.87 | 0.091 |
| CRP, mg/L | 30.87 ± 38.57 | 30.70 ± 38.47 | 31.48 ± 40.10 | 0.941 |
Categorical variables were compared using the chi-square test and continuous variables were compared using the t-test or Wilcoxon rank-sum test as appropriate. Numbers are the mean (SD), median (IQR), or frequency (percentage). *p < 0.05. ND, neurological deterioration; nND, non-neurological deterioration; SD, standard deviation; IQR, interquartile range; NIHSS, National Institute of Health Stroke Scale; WBC, white blood cell; Neu, neutrophil; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low- density lipoprotein; CRP, C-reactive protein.